Calcium channel blocker

DRUG5 trials

Sponsors

Ain Shams University, Yale University, Curtin University, Abant Izzet Baysal University, Minia University

Conditions

AnginaBreast CancerContrast-induced NephropathyFall RiskFear of FallingHypertensionHypertension,EssentialPostural Balance

Early Phase 1

Role of Amlodipine in Reduction of CIN

Not yet recruitingNCT07291375

Minia UniversityContrast-induced Nephropathy

Start: 2025-12-20End: 2026-07-01Target: 40Updated: 2025-12-18

Phase 2

Comparative Study Between Nicorandil and Nifedipine for the Treatment of Preterm Labour

Ain Shams UniversityPreterm Labor With Preterm Delivery

Start: 2020-06-01End: 2021-07-01Target: 230Updated: 2021-04-15

Phase 4

LIVEBETTER: A Trial Comparing Medications in Older Adults With Stable Angina and Multiple Chronic Conditions

RecruitingNCT05786417

Yale UniversityAngina, Stable Ischemic Heart Disease

Start: 2023-05-10End: 2027-05-30Target: 741Updated: 2025-12-03

Unknown Phase

Long-term Use of CCB and Breast Cancer Risk

Active, not recruitingNCT05972785

Curtin UniversityBreast Cancer, Hypertension,Essential

Start: 2022-07-01End: 2025-12-31Target: 68500Updated: 2024-08-21

Short-Term Effects of Antihypertensive Drugs on Postural Balance and Fall Risk

RecruitingNCT07099677

Abant Izzet Baysal UniversityFall Risk, Fear of Falling, Hypertension +1

Start: 2025-08-01End: 2026-06-30Target: 186Updated: 2026-02-12

Related Papers

Association between long-term use of calcium channel blockers (CCB) and the risk of breast cancer: a retrospective longitudinal observational study protocol

BMJ Open2024-03-012 citations